, Volume 81, Issue 1, pp 86–88 | Cite as

Digoxin-related impairment of learning and memory in cardiac patients

  • A. R. Tucker
  • K. T. Ng
Rapid Communication


The relationship between the plasma level of the cardiac glycoside digoxin and performance on a range of cognitive tasks was investigated in a group of cardiac outpatients on maintenance therapy. The cognitive functions assessed were speed of decision-making and recognition memory of nonverbal and verbal material, competitive audiovisual attention performance, visuo-motor-choice reaction time and auditory verbal learning (AVL). Multiple regression analysis of the data revealed a strong relationship between plasma digoxin level at the time of testing and the number of trials to criterion in the AVL task (plasma digoxin level 0.7–1.8 nmol/l). Further data analysis indicated that this association was unlikely to be due to age, education or severity of cardiac disorder. The results strongly suggest that an increasing plasma level of digoxin may produce a progressive deterioration in auditory verbal learning and short-term memory.

Key words

Digoxin Learning Memory Plasma level Cardiac patients 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Butler VP (1978) Evaluation of different methods for determining serum concentrations of cardiac glycosides. In: Bodem G, Dengler HJ (eds) Cardiac glycosides. Springer, Berlin Heidelberg New York, pp 1–17Google Scholar
  2. Buschke H, Fuld PA (1974) Evaluating storage, retention and retrieval in disordered memory and learning. Neurology 24:1019–1025Google Scholar
  3. Criteria Committee of the New York Heart Association (1964) New York Heart Association Functional Classification of Heart Disease. Little, Brown and Co, BostonGoogle Scholar
  4. Gorelick DA, Kussin SZ, Kahn I (1978) Paranoid deusions and auditory hallucinations associated with digoxin intoxication. J Nerv Ment Dis 166:817–819Google Scholar
  5. McNemar Q (1962) Psychological statistics. Wiley, New YorkGoogle Scholar
  6. Moe GK, Farah AE (1970) Digitalis and allied cardiac glycosides. In: Goodman LS, Gillman A (eds) The pharmacological basis of therapeutics. Macmillan, New York, pp 677–708Google Scholar
  7. Rietbrock N, Alken RG (1980) Colour vision deficiencies: A common sign of intoxication in chronically digoxin-treated patients. J Cardiovasc Pharm 2:93–99Google Scholar
  8. Schapel GJ, Read TRC (1980) Survey of cardiac failure therapy in Australian medical practice. Med J Aust 2:549–550Google Scholar
  9. Snedecor GW, Cochran WG (1967) Statistical methods. Iowa State University Press, AmesGoogle Scholar
  10. Tucker AR, Gibbs ME (1979) Saccharin aversion memory in rats: Inhibition of cycloheximide resistent memory by ouabain. Physiol Behav 23:341–346Google Scholar
  11. Tucker AR, Huppert FA, Petch MC (1980) Does digoxin impair cognitive functioning? In: Molloy M, Stanley GV, Walsh KW (eds) Brain impairment: Proceedings of the 1979 brain impairment workshop. University of Melbourne, Melbourne, pp 170–182Google Scholar
  12. Watts ME, Mark RF (1970) Drug inhibition of memory formation in chickens. II. Short-term memory. Proc R Soc Lond (B) 178:455–464Google Scholar
  13. Whitty CWM, Stores G, Lishman WA (1977) Amnesia in cerebral disease. In: Whitty CWM, Zangwill OL (eds) Amnesia. Butterworths, London, pp 52–92Google Scholar

Copyright information

© Springer-Verlag 1983

Authors and Affiliations

  • A. R. Tucker
    • 1
  • K. T. Ng
    • 1
  1. 1.Department of PsychologyLa Trobe UniversityBundooraAustralia

Personalised recommendations